Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06724068
NCT06724068
Completed
Not Applicable

The Correlation Between Diabetes, Insulin Resistance and Body Composition

Xuan Song1 site in 1 country515 target enrollmentDecember 17, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInsulin Resistance, Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Insulin Resistance, Diabetes
Sponsor
Xuan Song
Enrollment
515
Locations
1
Primary Endpoint
Prevalence of Sarcopenia in Diabetic Patients
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The goal of this retrospective study is to learn about the correlation between diabetes, insulin resistance and body compositions.

The main question[s] it aims to answer are:

  • [The difference of body composition between the individuals of insulin resistance and diabetes]
  • [The effect of diabetes on body composition]
Registry
clinicaltrials.gov
Start Date
December 17, 2021
End Date
August 31, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Xuan Song
Responsible Party
Sponsor Investigator
Principal Investigator

Xuan Song

Principal Investigator

Qianfoshan Hospital

Eligibility Criteria

Inclusion Criteria

  • •Adults aged 18 years and older.
  • •Diagnosed with type 2 diabetes mellitus according to recognized diagnostic criteria.
  • •Availability of complete body composition data (e.g., DXA measurements).
  • •Documented HbA1c levels and other glycemic control data.
  • •Continuous medical records available during the study period

Exclusion Criteria

  • •Presence of other severe metabolic diseases, such as liver failure or kidney failure.
  • •Use of medications affecting muscle mass (e.g., glucocorticoids) for more than three months.
  • •History of malignancy or ongoing treatment for cancer.
  • •Missing critical research data (e.g., diabetes duration or HbA1c levels).
  • •History of surgeries causing significant body composition changes (e.g., bariatric surgery).

Outcomes

Primary Outcomes

Prevalence of Sarcopenia in Diabetic Patients

Time Frame: Retrospective analysis of data collected between2019 and 2022

The proportion of diabetic patients diagnosed with sarcopenia, assessed based on measurements of muscle mass, muscle strength, and physical performance. Sarcopenia will be defined according to AWGS 2019 and EWGSOP2

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Insulin Resistance in Atopic Dermatitis PatientsAtopic Dermatitis
NCT05904509Bezmialem Vakif University32
Completed
Not Applicable
Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin EffectInsulin ResistanceGlucose Intolerance
NCT00784745University Hospital, Gentofte, Copenhagen21
Completed
Not Applicable
Study of Insulin Resistance and Endometrial Cancer in Harris County, TexasEndometrial Cancer
NCT00495235M.D. Anderson Cancer Center147
Completed
Not Applicable
Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's LipodystrophyLipodystrophyDunnigan Syndrome
NCT05424913Centre Hospitalier Universitaire de la Réunion150
Completed
Not Applicable
Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal IrradiationChildhood Cancer Survivors Treated With Abdominal Radiation
NCT02248779Memorial Sloan Kettering Cancer Center42